NRIX · Company research
Nurix Therapeutics, Inc. Common stock (NRIX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 22.73 | $2,629,368,292.41 | 2561683292.41 | — | — | — | 290.7628322912750194 | 6.5305314656245110 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.